Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin

Colorectal cancer is occasionally called colon or rectal cancer, depending on where cancer begins to form, and is the second leading cause of cancer death among both men and women. The platinum-based [PtCl(8-O-quinolinate)(dmso)] (8-QO-Pt) compound has demonstrated encouraging anticancer activity....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Boztepe, Tugce, Scioli Montoto, Sebastián, Gambaro, Rocío Celeste, Ruiz, María Esperanza, Cabrera, Silvia, Alemán, José, Islan, Germán Abel, Castro, Guillermo Raúl, León, Ignacio Esteban
Formato: Articulo
Lenguaje:Español
Publicado: 2023
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/153423
Aporte de:
id I19-R120-10915-153423
record_format dspace
spelling I19-R120-10915-1534232023-05-23T04:06:42Z http://sedici.unlp.edu.ar/handle/10915/153423 Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin Boztepe, Tugce Scioli Montoto, Sebastián Gambaro, Rocío Celeste Ruiz, María Esperanza Cabrera, Silvia Alemán, José Islan, Germán Abel Castro, Guillermo Raúl León, Ignacio Esteban 2023 2023-05-22T17:41:36Z es Química Drug delivery Colorectal cancer Platinum Riboflavin Colorectal cancer is occasionally called colon or rectal cancer, depending on where cancer begins to form, and is the second leading cause of cancer death among both men and women. The platinum-based [PtCl(8-O-quinolinate)(dmso)] (8-QO-Pt) compound has demonstrated encouraging anticancer activity. Three different systems of 8-QO-Pt-encapsulated nanostructured lipid carriers (NLCs) with riboflavin (RFV) were investigated. NLCs of myristyl myristate were synthesized by ultrasonication in the presence of RFV. RFV-decorated nanoparticles displayed a spherical shape and a narrow size dispersion in the range of 144–175 nm mean particle diameter. The 8-QO-Pt-loaded formulations of NLC/RFV with more than 70% encapsulation efficiency showed sustained in vitro release for 24 h. Cytotoxicity, cell uptake, and apoptosis were evaluated in the HT-29 human colorectal adenocarcinoma cell line. The results revealed that 8-QO-Pt-loaded formulations of NLC/RFV showed higher cytotoxicity than the free 8-QO-Pt compound at 5.0 M. All three systems exhibited different levels of cellular internalization. Moreover, the hemotoxicity assay showed the safety profile of the formulations (less than 3.7%). Taken together, RFV-targeted NLC systems for drug delivery have been investigated for the first time in our study and the results are promising for the future of chemotherapy in colon cancer treatment. Centro de Investigación y Desarrollo en Fermentaciones Industriales Laboratorio de Investigación y Desarrollo de Bioactivos Centro de Química Inorgánica Instituto de Genética Veterinaria Articulo Articulo http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International (CC BY 4.0) application/pdf
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Español
topic Química
Drug delivery
Colorectal cancer
Platinum
Riboflavin
spellingShingle Química
Drug delivery
Colorectal cancer
Platinum
Riboflavin
Boztepe, Tugce
Scioli Montoto, Sebastián
Gambaro, Rocío Celeste
Ruiz, María Esperanza
Cabrera, Silvia
Alemán, José
Islan, Germán Abel
Castro, Guillermo Raúl
León, Ignacio Esteban
Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
topic_facet Química
Drug delivery
Colorectal cancer
Platinum
Riboflavin
description Colorectal cancer is occasionally called colon or rectal cancer, depending on where cancer begins to form, and is the second leading cause of cancer death among both men and women. The platinum-based [PtCl(8-O-quinolinate)(dmso)] (8-QO-Pt) compound has demonstrated encouraging anticancer activity. Three different systems of 8-QO-Pt-encapsulated nanostructured lipid carriers (NLCs) with riboflavin (RFV) were investigated. NLCs of myristyl myristate were synthesized by ultrasonication in the presence of RFV. RFV-decorated nanoparticles displayed a spherical shape and a narrow size dispersion in the range of 144–175 nm mean particle diameter. The 8-QO-Pt-loaded formulations of NLC/RFV with more than 70% encapsulation efficiency showed sustained in vitro release for 24 h. Cytotoxicity, cell uptake, and apoptosis were evaluated in the HT-29 human colorectal adenocarcinoma cell line. The results revealed that 8-QO-Pt-loaded formulations of NLC/RFV showed higher cytotoxicity than the free 8-QO-Pt compound at 5.0 M. All three systems exhibited different levels of cellular internalization. Moreover, the hemotoxicity assay showed the safety profile of the formulations (less than 3.7%). Taken together, RFV-targeted NLC systems for drug delivery have been investigated for the first time in our study and the results are promising for the future of chemotherapy in colon cancer treatment.
format Articulo
Articulo
author Boztepe, Tugce
Scioli Montoto, Sebastián
Gambaro, Rocío Celeste
Ruiz, María Esperanza
Cabrera, Silvia
Alemán, José
Islan, Germán Abel
Castro, Guillermo Raúl
León, Ignacio Esteban
author_facet Boztepe, Tugce
Scioli Montoto, Sebastián
Gambaro, Rocío Celeste
Ruiz, María Esperanza
Cabrera, Silvia
Alemán, José
Islan, Germán Abel
Castro, Guillermo Raúl
León, Ignacio Esteban
author_sort Boztepe, Tugce
title Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
title_short Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
title_full Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
title_fullStr Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
title_full_unstemmed Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
title_sort design, synthesis, characterization, and evaluation of the anti-ht-29 colorectal cell line activity of novel 8-oxyquinolinate-platinum(ii)-loaded nanostructured lipid carriers targeted with riboflavin
publishDate 2023
url http://sedici.unlp.edu.ar/handle/10915/153423
work_keys_str_mv AT boztepetugce designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
AT sciolimontotosebastian designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
AT gambarorocioceleste designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
AT ruizmariaesperanza designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
AT cabrerasilvia designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
AT alemanjose designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
AT islangermanabel designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
AT castroguillermoraul designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
AT leonignacioesteban designsynthesischaracterizationandevaluationoftheantiht29colorectalcelllineactivityofnovel8oxyquinolinateplatinumiiloadednanostructuredlipidcarrierstargetedwithriboflavin
_version_ 1766999749705072640